Gobears: I know JP and speak with him weekly by phone. He

New Post Public Reply Private Reply Replies (3) Message Board
Daveludlow gobears1985 #13931
Gobears: I know JP and speak with him weekly by phone. He is a long and is not flipping or shorting. He is impatient with AMBS. He is not as concerned about hitting astronomical stock prices 5 to 6 years from now as he is about seeing increases in shareholder value now. That is the rub between different longs on the mb; some are purely long term investors while others are long, but they need to see the stock go up in the near term for a variety of reasons.

There are all kinds of people and investors and not all have the same investment profile. Just because JP and I need to see the stock get up to .20 cents or more by February doesn't mean we are flippers. We may simply have different objectives with the money we've invested here.

The drum beat about dilution shows our age and experience in other small young stocks like AMBS. We've seen this happen before where management uses dilution for years to move along their pipeline, always promising that increases in shareholder value are just around the corner....but there's always another corner and the promised increase in value doesn't come for years.

Longs like JP and I want management to know that we'd rather them take some up front money now instead of always "going it alone" to get more money down the road. Obviously, we want a reasonable deal in the present, we don't want management to give things away. But we want to impress management that they can't always live in the future.....on our dime....through dilution. They need to bring in some revenue or cash from deals so that the pps continues going up as we go. Waiting for 3 to 5 years before significant increases doesn't fit certain types of longs. Stock price wise 2014 was a bust compared to the way Gerald spoke about it at the end of 2013. The company's market cap increased, but because of dilution, shareholder value didn't increase.

Gobears, I know you are a long, but I also know JP is a long, you both just have different time frames. JP is not a Solantey or Biotechexpert who are clearly traders.

I assure you both JP and I have our fingers crossed that Gerald has the goods this time and our pps will finally get the lift off we've all been patiently waiting for.

I think by February we'll be above .20 cents and we'll all be happy with the progress.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Signing Day Sports Stock Hits Troubling New Low Amid Changes

Updated Category News Views 218

Stock Performance Overview In the midst of a challenging market landscape, Signing Day Sports (SGN) has seen its stock hit a concerning 52-week low, plunging to just $2.15. This drop is alarming and reveals the company's current financial struggles, which are evidenced by a notably weak financial health score and a current ratio of only 0.09. Such numbers suggest...

Continue Reading
Spero Therapeutics Unveils Positive Results for SPR720 Drug Trials

Updated Category News Views 138

Encouraging Outcomes from Spero Therapeutics' SPR720 Trials Spero Therapeutics, Inc. (NASDAQ: SPRO), a biopharmaceutical company devoted to developing treatments for rare diseases and multi-drug resistant bacterial infections, recently revealed promising results from its Phase 1 clinical trials for the drug candidate SPR720. This study focused specifically on...

Continue Reading
Ardagh Metal Packaging's Major Green Notes Pricing Announcement

Updated Category News Views 176

Ardagh Metal Packaging Prices $1,290 Million Senior Secured Green Notes Ardagh Metal Packaging S.A. (AMP) has made a significant announcement regarding the pricing of an issue of $1,290 million in senior secured green notes. This issuance comprises $620 million of 6.250% senior secured green notes due in 2031 at a price of 100%, representing a yield of 6.250%....

Continue Reading
Imperial Petroleum Sees Growth Amid Market Challenges in 2025

Updated Category News Views 162

Introduction to Financial Results IMPERIAL PETROLEUM INC. (NASDAQ: IMPP) has reported its unaudited financial and operating results for the second quarter and the first half of 2025. This ship-owning company specializes in petroleum products, crude oil, and dry bulk seaborne transportation services. The results of this period reflect a strategic approach in navigating the...

Continue Reading
Explore St. Louis Welcomes Brad Dean as New CEO and President

Updated Category News Views 640

Explore St. Louis Welcomes Brad Dean as Its New Leader Explore St. Louis has made an exciting announcement regarding its leadership. After a thorough nationwide search, the organization has appointed Brad Dean as its new President and CEO. This transition marks a pivotal moment for Explore St. Louis as it aims to elevate the tourism and convention industry in the area....

Continue Reading